During the first quarter of 2014 start-up companies raised $1.18 billion, up $2.8 million from last quarter’s impressive total and setting a new record for start-up fundraising since we began featuring this column five years ago. Biopharma companies pulled in 92% ($1.08 billion), of which 59% was the result of public financings. Eight medical device firms together generated $75.2 million, while only two in vitro diagnostics companies raised a combined $23.1 million (down from the $81 million in Q4 2013). (See Exhibit 1.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?